These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9030191

  • 1. Characterization of human apolipoprotein A-I expressed in Escherichia coli.
    Bergeron J, Frank PG, Emmanuel F, Latta M, Zhao Y, Sparks DL, Rassart E, Denèfle P, Marcel YL.
    Biochim Biophys Acta; 1997 Jan 21; 1344(2):139-52. PubMed ID: 9030191
    [Abstract] [Full Text] [Related]

  • 2. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.
    Sparks DL, Frank PG, Neville TA.
    Biochim Biophys Acta; 1998 Feb 16; 1390(2):160-72. PubMed ID: 9507105
    [Abstract] [Full Text] [Related]

  • 3. Deletion of central alpha-helices in human apolipoprotein A-I: effect on phospholipid association.
    Frank PG, Bergeron J, Emmanuel F, Lavigne JP, Sparks DL, Denèfle P, Rassart E, Marcel YL.
    Biochemistry; 1997 Feb 18; 36(7):1798-806. PubMed ID: 9048564
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Specific phospholipid association with apolipoprotein A-I stimulates cholesterol efflux from human fibroblasts. Studies with reconstituted sonicated lipoproteins.
    Zhao Y, Sparks DL, Marcel YL.
    J Biol Chem; 1996 Oct 11; 271(41):25145-51. PubMed ID: 8810270
    [Abstract] [Full Text] [Related]

  • 6. Effect of the cholesterol content of reconstituted LpA-I on lecithin:cholesterol acyltransferase activity.
    Sparks DL, Anantharamaiah GM, Segrest JP, Phillips MC.
    J Biol Chem; 1995 Mar 10; 270(10):5151-7. PubMed ID: 7890624
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins.
    Frank PG, N'Guyen D, Franklin V, Neville T, Desforges M, Rassart E, Sparks DL, Marcel YL.
    Biochemistry; 1998 Sep 29; 37(39):13902-9. PubMed ID: 9753480
    [Abstract] [Full Text] [Related]

  • 10. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding.
    Minnich A, Collet X, Roghani A, Cladaras C, Hamilton RL, Fielding CJ, Zannis VI.
    J Biol Chem; 1992 Aug 15; 267(23):16553-60. PubMed ID: 1644835
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The conformation of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. 13C NMR studies of lysine ionization behavior.
    Sparks DL, Phillips MC, Lund-Katz S.
    J Biol Chem; 1992 Dec 25; 267(36):25830-8. PubMed ID: 1464597
    [Abstract] [Full Text] [Related]

  • 15. Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg).
    von Eckardstein A, Castro G, Wybranska I, Theret N, Duchateau P, Duverger N, Fruchart JC, Ailhaud G, Assmann G.
    J Biol Chem; 1993 Feb 05; 268(4):2616-22. PubMed ID: 8428938
    [Abstract] [Full Text] [Related]

  • 16. Apolipoprotein A-I domains involved in the activation of lecithin:cholesterol acyltransferase. Importance of the central domain.
    Meng QH, Calabresi L, Fruchart JC, Marcel YL.
    J Biol Chem; 1993 Aug 15; 268(23):16966-73. PubMed ID: 7688720
    [Abstract] [Full Text] [Related]

  • 17. A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction.
    Huang W, Sasaki J, Matsunaga A, Han H, Li W, Koga T, Kugi M, Ando S, Arakawa K.
    Arterioscler Thromb Vasc Biol; 2000 Jan 15; 20(1):210-6. PubMed ID: 10634820
    [Abstract] [Full Text] [Related]

  • 18. High yield overexpression and characterization of human recombinant proapolipoprotein A-I.
    McGuire KA, Davidson WS, Jonas A.
    J Lipid Res; 1996 Jul 15; 37(7):1519-28. PubMed ID: 8827524
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux.
    Daum U, Langer C, Duverger N, Emmanuel F, Benoit P, Denèfle P, Chirazi A, Cullen P, Pritchard PH, Bruckert E, Assmann G, von Eckardstein A.
    J Mol Med (Berl); 1999 Aug 15; 77(8):614-22. PubMed ID: 10543393
    [Abstract] [Full Text] [Related]

  • 20. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
    Lindholm EM, Bielicki JK, Curtiss LK, Rubin EM, Forte TM.
    Biochemistry; 1998 Apr 07; 37(14):4863-8. PubMed ID: 9538003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.